Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

2011 Surveillance Slides

This webpage is archived for historical purposes and is no longer being maintained or updated.

Surveillance Slides Previous Slide
Slide 29: Completion of TB Therapy, United States, 1993-2009.

Slide 29. Completion of TB Therapy, United States, 1993–2009. The reporting areas began providing infor­mation on completion of therapy in 1993 through the individual TB case report form. The calculations exclude persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture. Overall completion of therapy had remained at approximately 92-93% from 1998 through 2008, but increased to 95% in 2009.. Completion in 1 year or less increased from 64% in 1993 to 88% in 2009, the latest year with available data. The current DHHS Healthy People 2020 objective is comple­tion of therapy in 1 year or less in 93% of patients. CDC is working with state and local health departments to determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

Back to 2011 Surveillance Slides Main Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO